Stay updated on Palbociclib in Metastatic Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Palbociclib in Metastatic Breast Cancer Clinical Trial page.

Latest updates to the Palbociclib in Metastatic Breast Cancer Clinical Trial page
- ChecktodayChange DetectedPALOMA-3 reference updated to reflect the published erratum and associated corrections in Lancet Oncology.SummaryDifference0.0%

- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check22 days agoChange DetectedThe page shows a revision tag update from v3.4.2 to v3.4.3. The study content and page layout appear unchanged.SummaryDifference0.0%

- Check29 days agoChange DetectedThe Publications entry for the PALOMA-3 final analysis has been updated to include the Erratum and a 2016 July update, replacing the shorter citation with the expanded reference.SummaryDifference0.0%

- Check43 days agoChange DetectedResults posted on 2026-02-12 with expanded primary and secondary outcomes and time frames (PFS, OS, ORR, DOR, CBR). New documents and data sections were added, including the Study Protocol and Statistical Analysis Plan PDF, PK data, PIK3CA biomarker analyses, and tumor biomarker data.SummaryDifference0.9%

- Check50 days agoChange DetectedAdded a site revision tag 'Revision: v3.4.2' and removed older funding notices including 'Revision: v3.4.1' and the lapse-in-funding message. Core study content and navigation remain unchanged.SummaryDifference0.2%

Stay in the know with updates to Palbociclib in Metastatic Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Palbociclib in Metastatic Breast Cancer Clinical Trial page.